Insider trade

Director received an award of 49 HUM derivative securities

Traded Dec 31, 2025 · Filed Jan 5, 2026

HumanaHUM

49
Derivative units · @ $258.87

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Dec 31, 2025
Reporting period: Not applicable
Filed with the SEC: Jan 5, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001157619-26-000003
Filed / recorded

Jan 5, 2026, 2:31 PM UTC

Added to OQRO

Oct 2, 2026, 12:28 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

HUMANA INC

Issuer CIK

49071

Ticker

HUM

Reporting person

Karen Katz

Relationship

Director

Security

Restricted Stock Units

Table

Derivative (Table II)

Transaction date

Dec 31, 2025

Transaction code

A

Shares / units

49

Price per share

$258.87

Acquired / disposed

Acquired (A)

Shares owned after

124

Ownership form

Direct

Amendment

No

Footnotes from the filing

Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until her resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).